Related Experiment Video
Updated: Aug 22, 2025
05:06
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
15.4K
C-Series Coelenterazine-Driven Bioluminescence Signature Imaging
Genta Kamiya1, Nobuo Kitada1, Tadaomi Furuta2
1Department of Engineering Science, Graduate School of Informatics and Engineering, The University of Electro-Communications, Chofu 182-8585, Japan.
International Journal of Molecular Sciences
|November 11, 2022
Summary
Researchers developed novel CTZ analogues for bioluminescence (BL) imaging. Four C-series analogues exhibit distinct BL signatures, enabling multiplexed reporter systems for advanced bioassays.
Area of Science:
- Biochemistry
- Molecular Biology
- Bioimaging
Background:
- Bioluminescence (BL) imaging is crucial for biological research.
- Developing novel reporters with distinct spectral signatures is essential for multiplexing.
Purpose of the Study:
- To introduce a novel bioluminescence signature imaging system using new CTZ analogues.
- To characterize the spectral signatures and intensity patterns of these analogues with different luciferases.
Main Methods:
- Synthesis of nine C-series CTZ analogues.
- Examination of BL intensity patterns and spectra with marine luciferases (Renilla luciferase, NanoLuc, artificial luciferase).
- Development of multi-reporter and multi-probe systems using selected analogues.
Main Results:
- Four CTZ analogues (C3, C4, C6, C7) demonstrated unique BL spectral signatures and intensity patterns.
- These analogues showed distinct luminescence profiles with RLuc, NanoLuc, and ALuc.
- Successful multiplexing into multi-reporter and multi-probe systems was achieved.
Conclusions:
- The novel C-series CTZ analogues provide unique BL signatures for reporter systems.
- This methodology enables precise signal specification in single- and multi-reporter assays.
- The study offers a unique approach to conventional bioassays using distinct bioluminescence patterns.
